Company Filing History:
Years Active: 2017
Title: Paola Di Lello: Innovator in Cancer Treatment
Introduction
Paola Di Lello is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. Her work focuses on modulating USP7, a critical protein involved in various cellular processes.
Latest Patents
Paola holds a patent for USP7 inhibitor compounds and methods of use. The patent describes 2-Aminopyridine compounds of Formula I, which include various substituents such as stereoisomers, tautomers, and pharmaceutically acceptable salts. These compounds are useful for modulating USP7 and for treating cancer and immune disorders, including inflammation mediated by USP7. The patent also discloses methods for using these compounds in vitro, in situ, and in vivo for the diagnosis and treatment of related disorders in mammalian cells.
Career Highlights
Throughout her career, Paola has worked with leading companies in the pharmaceutical industry, including Genentech, Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop her expertise in drug discovery and development, particularly in the area of cancer therapeutics.
Collaborations
Paola has collaborated with notable professionals in her field, including Robert Anthony Blake and Jason Drummond. These collaborations have further enhanced her research and contributed to the advancement of her innovative work.
Conclusion
Paola Di Lello is a trailblazer in the field of cancer treatment, with a focus on USP7 inhibitor compounds. Her contributions to pharmaceutical research and development are paving the way for new therapeutic options for patients.